|
Volumn 103, Issue 24, 2001, Pages 3019-3041
|
ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines) - Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary angioplasty) Endorsed by the society for Cardiac Angiography and Interventions
a,a a a a a a a a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ALTEPLASE;
ANTIBIOTIC AGENT;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
CONTRAST MEDIUM;
CYCLOSPORIN;
DALTEPARIN;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
HEPARIN;
LAMIFIBAN;
LOW MOLECULAR WEIGHT HEPARIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
OXYGEN;
TICLOPIDINE;
TIROFIBAN;
ANGINA PECTORIS;
ANGIOCARDIOGRAPHY;
ASSISTED CIRCULATION;
CARDIOGENIC SHOCK;
CLINICAL TRIAL;
CORONARY ARTERY BLOOD FLOW;
CORONARY ARTERY BYPASS SURGERY;
CORONARY ARTERY DISEASE;
CORONARY ARTERY PRESSURE;
CORONARY STENT;
COST EFFECTIVENESS ANALYSIS;
DISEASE CLASSIFICATION;
DOPPLER FLOWMETRY;
DRUG EFFECT;
DRUG EFFICACY;
EVIDENCE BASED MEDICINE;
EXERCISE TEST;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HEART TRANSPLANTATION;
HOSPITAL CARE;
HUMAN;
IATROGENIC DISEASE;
INTERMETHOD COMPARISON;
INTRAVASCULAR ULTRASOUND;
NEPHROTOXICITY;
PATIENT SELECTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RESTENOSIS;
REVIEW;
RISK FACTOR;
THROMBOCYTOPENIC PURPURA;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT INDICATION;
TREATMENT OUTCOME;
UNSTABLE ANGINA PECTORIS;
|
EID: 0035912690
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.cir.103.24.3019 Document Type: Review |
Times cited : (466)
|
References (0)
|